Institutional Ownership X4 Pharmaceuticals, Inc (XFOR)
This table provides information about the institutional ownership of X4 Pharmaceuticals, Inc (XFOR). We have compiled data on the 100 institutions that hold shares in the stock, with a total of 97.9 Million shares, which have been reported (via 13F filing form) to have a value of $265 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
16,915,784
shares
|
$54.6 Million
1.36% of portfolio
|
Q4 2023
Added 5.98%
|
|
Nea Management Company, LLC
Timonium, MD |
May 14, 2025 Q1 2025 |
14,986,793
shares
|
$48.4 Million
0.34% of portfolio
|
Q2 2023
Added 27.69%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,675,963
shares
|
$34.5 Million
0.0% of portfolio
|
Q2 2024
Added 22.21%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
8,067,516
shares
|
$26.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.63%
|
|
Acorn Capital Advisors, LLC
New York, NY |
May 15, 2025 Q1 2025 |
7,310,650
shares
|
$23.6 Million
1.22% of portfolio
|
Q4 2024
New holding
|
|
Kingdon Capital Management, L.L.C.
New York, NY |
May 15, 2025 Q1 2025 |
7,000,000
shares
|
$22.6 Million
0.19% of portfolio
|
Q1 2025
Added 41.79%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
6,776,515
shares
|
$21.9 Million
0.05% of portfolio
|
Q1 2025
Reduced 5.0%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
5,037,183
shares
|
$16.3 Million
0.0% of portfolio
|
Q1 2025
Added 445.7%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
3,619,682
shares
|
$11.7 Million
0.0% of portfolio
|
Q1 2025
Added 3.5%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
3,055,081
shares
|
$9.87 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.07%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
2,235,655
shares
|
$7.22 Million
0.0% of portfolio
|
Q1 2025
Reduced 12.21%
|
|
Pale Fire Capital Se
Prague, 2N |
May 14, 2025 Q1 2025 |
2,035,362
shares
|
$6.57 Million
0.06% of portfolio
|
Q1 2025
Added 45.18%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
1,712,361
shares
|
$5.53 Million
0.0% of portfolio
|
Q1 2025
Reduced 9.28%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,253,815
shares
|
$4.05 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.64%
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
691,116
shares
|
$2.23 Million
0.0% of portfolio
|
Q1 2025
Reduced 77.5%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
650,000
shares
|
$2.1 Million
0.0% of portfolio
|
Q4 2024
Added 3.99%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
570,011
shares
|
$1.84 Million
0.0% of portfolio
|
Q1 2025
Added 3.55%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
481,528
shares
|
$1.56 Million
0.0% of portfolio
|
Q1 2025
Added 9.89%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
335,436
shares
|
$1.08 Million
0.0% of portfolio
|
Q1 2025
Reduced 75.92%
|
|
Sv Health Investors, LLC
Boston, MA |
Nov 07, 2022 Q3 2022 |
311,490
shares
|
$1.01 Million
1.65% of portfolio
|
Q1 2019
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
273,865
shares
|
$884,583
0.0% of portfolio
|
Q1 2025
Reduced 42.66%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
267,628
shares
|
$864,438
0.0% of portfolio
|
Q4 2024
Added 559.56%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
258,759
shares
|
$835,791
0.0% of portfolio
|
Q4 2024
Reduced 28.76%
|
|
Ajo Vista, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
257,644
shares
|
$832,190
0.75% of portfolio
|
Q3 2024
New holding
|
|
Ubs Oconnor LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
252,602
shares
|
$815,904
0.0% of portfolio
|
Q1 2025
Reduced 80.02%
|